Use of Biomarkers in Clinical Trials

First Page		Document Content
Medical research Clinical trials Epidemiology Medical terms Biotechnology Biomarker Surrogate endpoint Clinical endpoint Imaging biomarker Medicine Biology Health		Use of Biomarkers in Clinical Trials Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 846,73 KB Share Document on Facebook

	Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather DocID: 1vpIt - View Document
	Clinical Trial Imaging Endpoint Process Standards Guidance for Industry U.S. Department of Health and Human Services DocID: 1uZ89 - View Document
	NARBHAnet Documentation of Security Measures for Clinical Videoconferencing Connections This form is required as written documentation that security measures are in place for all videoconference endpoints and connections DocID: 1rm4X - View Document
	A Video Game Improves Behavioral Outcomes in Adolescents and Young Adults With Cancer: A Randomized Trial DocID: 1rjlO - View Document
	United States Government Accountability Office GAO Report to the Ranking Member, Committee on Finance, U.S. Senate DocID: 1riEa - View Document